Class-Specific Histone Deacetylase Inhibitors Promote 11-Beta Hydroxysteroid Dehydrogenase Type 2 Expression in JEG-3 Cells

Exposure to maternal cortisol plays a crucial role in fetal organogenesis. However, fetal overexposure to cortisol has been linked to a range of short- and long-term adverse outcomes. Normally, this is prevented by the expression of an enzyme in the placenta called 11-beta hydroxysteroid dehydrogena...

Full description

Saved in:
Bibliographic Details
Main Authors: Katie L. Togher, Louise C. Kenny, Gerard W. O’Keeffe
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:International Journal of Cell Biology
Online Access:http://dx.doi.org/10.1155/2017/6169310
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566199328702464
author Katie L. Togher
Louise C. Kenny
Gerard W. O’Keeffe
author_facet Katie L. Togher
Louise C. Kenny
Gerard W. O’Keeffe
author_sort Katie L. Togher
collection DOAJ
description Exposure to maternal cortisol plays a crucial role in fetal organogenesis. However, fetal overexposure to cortisol has been linked to a range of short- and long-term adverse outcomes. Normally, this is prevented by the expression of an enzyme in the placenta called 11-beta hydroxysteroid dehydrogenase type 2 (11β-HSD2) which converts active cortisol to its inactive metabolite cortisone. Placental 11β-HSD2 is known to be reduced in a number of adverse pregnancy complications, possibly through an epigenetic mechanism. As a result, a number of pan-HDAC inhibitors have been examined for their ability to promote 11β-HSD2 expression. However, it is not known if the effects of pan-HDAC inhibition are a general phenomenon or if the effects are dependent upon a specific class of HDACs. Here, we examined the ability of pan- and class-specific HDAC inhibitors to regulate 11β-HSD2 expression in JEG3 cells. We find that pan-, class I, or class IIa HDAC inhibition promoted 11β-HSD2 expression and prevented cortisol or interleukin-1β-induced decrease in its expression. These results demonstrate that targeting a specific class of HDACs can promote 11β-HSD2 expression in JEG3 cells. This adds to the growing body of evidence suggesting that HDACs may be crucial in maintaining normal fetal development.
format Article
id doaj-art-469abb8a4599448b8c8ae4e34233fdc1
institution Kabale University
issn 1687-8876
1687-8884
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series International Journal of Cell Biology
spelling doaj-art-469abb8a4599448b8c8ae4e34233fdc12025-02-03T01:04:50ZengWileyInternational Journal of Cell Biology1687-88761687-88842017-01-01201710.1155/2017/61693106169310Class-Specific Histone Deacetylase Inhibitors Promote 11-Beta Hydroxysteroid Dehydrogenase Type 2 Expression in JEG-3 CellsKatie L. Togher0Louise C. Kenny1Gerard W. O’Keeffe2Department of Obstetrics and Gynaecology, Cork University Maternity Hospital, University College Cork, Cork, IrelandDepartment of Obstetrics and Gynaecology, Cork University Maternity Hospital, University College Cork, Cork, IrelandAPC Microbiome Institute, Biosciences Institute, University College Cork, Cork, IrelandExposure to maternal cortisol plays a crucial role in fetal organogenesis. However, fetal overexposure to cortisol has been linked to a range of short- and long-term adverse outcomes. Normally, this is prevented by the expression of an enzyme in the placenta called 11-beta hydroxysteroid dehydrogenase type 2 (11β-HSD2) which converts active cortisol to its inactive metabolite cortisone. Placental 11β-HSD2 is known to be reduced in a number of adverse pregnancy complications, possibly through an epigenetic mechanism. As a result, a number of pan-HDAC inhibitors have been examined for their ability to promote 11β-HSD2 expression. However, it is not known if the effects of pan-HDAC inhibition are a general phenomenon or if the effects are dependent upon a specific class of HDACs. Here, we examined the ability of pan- and class-specific HDAC inhibitors to regulate 11β-HSD2 expression in JEG3 cells. We find that pan-, class I, or class IIa HDAC inhibition promoted 11β-HSD2 expression and prevented cortisol or interleukin-1β-induced decrease in its expression. These results demonstrate that targeting a specific class of HDACs can promote 11β-HSD2 expression in JEG3 cells. This adds to the growing body of evidence suggesting that HDACs may be crucial in maintaining normal fetal development.http://dx.doi.org/10.1155/2017/6169310
spellingShingle Katie L. Togher
Louise C. Kenny
Gerard W. O’Keeffe
Class-Specific Histone Deacetylase Inhibitors Promote 11-Beta Hydroxysteroid Dehydrogenase Type 2 Expression in JEG-3 Cells
International Journal of Cell Biology
title Class-Specific Histone Deacetylase Inhibitors Promote 11-Beta Hydroxysteroid Dehydrogenase Type 2 Expression in JEG-3 Cells
title_full Class-Specific Histone Deacetylase Inhibitors Promote 11-Beta Hydroxysteroid Dehydrogenase Type 2 Expression in JEG-3 Cells
title_fullStr Class-Specific Histone Deacetylase Inhibitors Promote 11-Beta Hydroxysteroid Dehydrogenase Type 2 Expression in JEG-3 Cells
title_full_unstemmed Class-Specific Histone Deacetylase Inhibitors Promote 11-Beta Hydroxysteroid Dehydrogenase Type 2 Expression in JEG-3 Cells
title_short Class-Specific Histone Deacetylase Inhibitors Promote 11-Beta Hydroxysteroid Dehydrogenase Type 2 Expression in JEG-3 Cells
title_sort class specific histone deacetylase inhibitors promote 11 beta hydroxysteroid dehydrogenase type 2 expression in jeg 3 cells
url http://dx.doi.org/10.1155/2017/6169310
work_keys_str_mv AT katieltogher classspecifichistonedeacetylaseinhibitorspromote11betahydroxysteroiddehydrogenasetype2expressioninjeg3cells
AT louiseckenny classspecifichistonedeacetylaseinhibitorspromote11betahydroxysteroiddehydrogenasetype2expressioninjeg3cells
AT gerardwokeeffe classspecifichistonedeacetylaseinhibitorspromote11betahydroxysteroiddehydrogenasetype2expressioninjeg3cells